1. Medtech Insight
  3. >>Diagnostics

FDA Revokes Emergency Authorization On Ebola, Zika Tests

 
• By Elizabeth Orr

Emergency Use Authorizations on two Ebola tests and one for the Zika virus have been revoked by the US agency because it cleared the tests via more permanent pathways.

Positive Ebola test and laboratory sample of blood testing for diagnosis Ebola infection. Ebola virus disease(EVD)cause hemorrhagic fever(EHF).Tropical infectious and diagnostic technology concept

The US Food and Drug Administration has revoked emergency authorizations for two tests for the Ebola virus and one for Zika, saying the tests have since been cleared via other pathways.

The affected tests areOraSure Technologies Inc.’s OraQuick Ebola Rapid Antigen Test used with whole blood specimens and OraQuick Ebola...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diagnostics

More from Device Area

Fallouh Healthcare Receives Grant Funding From Innovate UK

 
• By Natasha Barrow

Fallouh Healthcare has received £305,050 in grant funding from Innovate UK as part of the European Union’s Eureka Eurostars program. The company aims to detect cardiac tamponade, a condition that affects patients after heart surgery. Currently, there is no way to accurately diagnose the condition.

Newborn Screening Tests Among FDA Classifications

 
• By Elizabeth Orr

The US FDA has announced classifications for five device types, including four diagnostics as well as a hand cream to protect healthcare workers exposed to radiation. Two of the products are newborn screening tests.

FDA Regulations ‘Lock Out’ Clinically Proven Neuromodulation Devices

 
• By Natasha Barrow

Flow Neuroscience's neuromodulation headset for the treatment of depression is approved and marketed in the EU. However, two years on, the company is still waiting for US FDA approval despite being assigned breakthrough device designation.